Year 2001 | Year 2007 | Year 2011 | P value for trend | |
---|---|---|---|---|
n = 210 | n = 327 | n = 302 | ||
% | % | % | ||
Medications | ||||
Aspirin | 87.1 | 94.2 | 94.4 | 0.003 |
P2Y12-receptor inhibitors | 17.1 | 61.5 | 70.5 | <0.001 |
Anticoagulants | 89.0 | 93.0 | 92.7 | 0.133 |
Glycoprotein IIb/IIIa inh. | 12.4 | 38.8 | 29.1 | <0.001 |
Betablockers | 79.5 | 82.6 | 82.1 | 0.452 |
Nitrates | 92.4 | 78.9 | 76.2 | <0.001 |
ACEi/ARB | 70.5 | 74.9 | 81.1 | 0.006 |
Statins | 26.7 | 67.9 | 77.2 | <0.001 |
Cardiac catheterization | 35.7 | 78.6 | 80.8 | <0.001 |
Revascularization | 27.6 | 64.2 | 73.5 | <0.001 |
PCI | 22.4 | 61.5 | 67.9 | <0.001 |
CABG | 5.2 | 3.7 | 6.0 | 0.722 |
Echocardiography | 81.9 | 85.3 | 88.4 | 0.044 |
Treatment for STEMI | n = 130 | n = 162 | n = 160 | |
Reperfusion for STEMI | 42.3 | 64.2 | 63.1 | <0.001 |
Thrombolysis | 35.4 | 7.4 | 0.6 | <0.001 |
Primary PCI | 6.9 | 56.8 | 62.5 | <0.001 |
Treatment for NSTEMI | n = 80 | n = 165 | n = 142 | |
PCI | 18.8 | 47.9 | 53.5 | <0.001 |
CABG | 7.5 | 3.6 | 9.2 | 0.56 |